146 related articles for article (PubMed ID: 30148623)
1. Acid-Activated Melittin for Targeted and Safe Antitumor Therapy.
Luo L; Wu W; Sun D; Dai HB; Wang Y; Zhong Y; Wang JX; Maruf A; Nurhidayah D; Zhang XJ; Wang Y; Wang GX
Bioconjug Chem; 2018 Sep; 29(9):2936-2944. PubMed ID: 30148623
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in melittin-based nanoparticles for antitumor treatment: from mechanisms to targeted delivery strategies.
Yu X; Jia S; Yu S; Chen Y; Zhang C; Chen H; Dai Y
J Nanobiotechnology; 2023 Nov; 21(1):454. PubMed ID: 38017537
[TBL] [Abstract][Full Text] [Related]
3. Melittin, a major peptide component of bee venom, and its conjugates in cancer therapy.
Rady I; Siddiqui IA; Rady M; Mukhtar H
Cancer Lett; 2017 Aug; 402():16-31. PubMed ID: 28536009
[TBL] [Abstract][Full Text] [Related]
4. Nanoscale Melittin@Zeolitic Imidazolate Frameworks for Enhanced Anticancer Activity and Mechanism Analysis.
Li Y; Xu N; Zhu W; Wang L; Liu B; Zhang J; Xie Z; Liu W
ACS Appl Mater Interfaces; 2018 Jul; 10(27):22974-22984. PubMed ID: 29920061
[TBL] [Abstract][Full Text] [Related]
5. Melittin liposomes surface modified with poloxamer 188: in vitro characterization and in vivo evaluation.
Tian JL; Ke X; Chen Z; Wang CJ; Zhang Y; Zhong TC
Pharmazie; 2011 May; 66(5):362-7. PubMed ID: 21699070
[TBL] [Abstract][Full Text] [Related]
6. Anti-Tumor Effects of Melittin and Its Potential Applications in Clinic.
Lyu C; Fang F; Li B
Curr Protein Pept Sci; 2019; 20(3):240-250. PubMed ID: 29895240
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulatory activities and biomedical applications of melittin and its recent advances.
Jafari Z; Sadeghi S; Dehaghi MM; Bigham A; Honarmand S; Tavasoli A; Hoseini MHM; Varma RS
Arch Pharm (Weinheim); 2024 Apr; 357(4):e2300569. PubMed ID: 38251938
[TBL] [Abstract][Full Text] [Related]
8. Stable Loading and Delivery of Melittin with Lipid-Coated Polymeric Nanoparticles for Effective Tumor Therapy with Negligible Systemic Toxicity.
Ye R; Zheng Y; Chen Y; Wei X; Shi S; Chen Y; Zhu W; Wang A; Yang L; Xu Y; Peng J
ACS Appl Mater Interfaces; 2021 Dec; 13(47):55902-55912. PubMed ID: 34793125
[TBL] [Abstract][Full Text] [Related]
9. Conformational studies of anionic melittin analogues: effect of peptide concentration, pH, ionic strength, and temperature--models for protein folding and halophilic proteins.
Ramalingam K; Aimoto S; Bello J
Biopolymers; 1992 Aug; 32(8):981-92. PubMed ID: 1420981
[TBL] [Abstract][Full Text] [Related]
10. Delivery Strategies for Melittin-Based Cancer Therapy.
Zhou J; Wan C; Cheng J; Huang H; Lovell JF; Jin H
ACS Appl Mater Interfaces; 2021 Apr; 13(15):17158-17173. PubMed ID: 33847113
[TBL] [Abstract][Full Text] [Related]
11. Structure and dynamics of melittin in lysomyristoyl phosphatidylcholine micelles determined by nuclear magnetic resonance.
Yuan P; Fisher PJ; Prendergast FG; Kemple MD
Biophys J; 1996 May; 70(5):2223-38. PubMed ID: 9172746
[TBL] [Abstract][Full Text] [Related]
12. Conformational and aggregational states of omega-aminoacylmelittin derivatives.
Ramalingam K; Bello J
Biochemistry; 1993 Jan; 32(1):253-9. PubMed ID: 8418844
[TBL] [Abstract][Full Text] [Related]
13. Effect of dimerized melittin on gastric cancer cells and antibacterial activity.
Jamasbi E; Lucky SS; Li W; Hossain MA; Gopalakrishnakone P; Separovic F
Amino Acids; 2018 Aug; 50(8):1101-1110. PubMed ID: 29770868
[TBL] [Abstract][Full Text] [Related]
14. Endosomolysis by masking of a membrane-active agent (EMMA) for cytoplasmic release of macromolecules.
Rozema DB; Ekena K; Lewis DL; Loomis AG; Wolff JA
Bioconjug Chem; 2003; 14(1):51-7. PubMed ID: 12526692
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and preliminary evaluation of poly(amidoamine)-melittin conjugates as endosomolytic polymers and/or potential anticancer therapeutics.
Lavignac N; Lazenby M; Franchini J; Ferruti P; Duncan R
Int J Pharm; 2005 Aug; 300(1-2):102-12. PubMed ID: 16009513
[TBL] [Abstract][Full Text] [Related]
16. N-terminus and lysine side chain pKa values of melittin in aqueous solutions and micellar dispersions measured by 15N NMR.
Zhu L; Kemple MD; Yuan P; Prendergast FG
Biochemistry; 1995 Oct; 34(40):13196-202. PubMed ID: 7548083
[TBL] [Abstract][Full Text] [Related]
17. Melittin peptides exhibit different activity on different cells and model membranes.
Jamasbi E; Batinovic S; Sharples RA; Sani MA; Robins-Browne RM; Wade JD; Separovic F; Hossain MA
Amino Acids; 2014 Dec; 46(12):2759-66. PubMed ID: 25200682
[TBL] [Abstract][Full Text] [Related]
18. Permethylation alters the conformational transitions and the complexing ability of melittin: a model for methylated proteins.
Ramalingam K; Bello J; Aimoto S
Biopolymers; 1993 Feb; 33(2):305-14. PubMed ID: 8485301
[TBL] [Abstract][Full Text] [Related]
19. Melittin-MIL-2 fusion protein as a candidate for cancer immunotherapy.
Liu M; Wang H; Liu L; Wang B; Sun G
J Transl Med; 2016 Jun; 14(1):155. PubMed ID: 27246873
[TBL] [Abstract][Full Text] [Related]
20. Contribution of proline-14 to the structure and actions of melittin.
Dempsey CE; Bazzo R; Harvey TS; Syperek I; Boheim G; Campbell ID
FEBS Lett; 1991 Apr; 281(1-2):240-4. PubMed ID: 2015901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
